These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 948376)
21. Occult bilateral involvement in stage I epithelial ovarian cancer. Benjamin I; Morgan MA; Rubin SC Gynecol Oncol; 1999 Mar; 72(3):288-91. PubMed ID: 10053097 [TBL] [Abstract][Full Text] [Related]
22. Bilateral metastatic ovarian tumors (Krukenberg's tumors) in the course of stomach cancer. Studzinski Z; Zajewski W Arch Gynecol Obstet; 2002 Dec; 267(2):95-7. PubMed ID: 12439555 [TBL] [Abstract][Full Text] [Related]
23. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701 [TBL] [Abstract][Full Text] [Related]
24. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors]. Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198 [TBL] [Abstract][Full Text] [Related]
25. Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall. Lewis MR; Euscher ED; Deavers MT; Silva EG; Malpica A Gynecol Oncol; 2007 May; 105(2):395-8. PubMed ID: 17335881 [TBL] [Abstract][Full Text] [Related]
26. Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma. Soper JT; Johnson P; Johnson V; Berchuck A; Clarke-Pearson DL Obstet Gynecol; 1992 Dec; 80(6):949-53. PubMed ID: 1333065 [TBL] [Abstract][Full Text] [Related]
27. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Pereira A; Magrina JF; Rey V; Cortes M; Magtibay PM Gynecol Oncol; 2007 Jun; 105(3):604-8. PubMed ID: 17321572 [TBL] [Abstract][Full Text] [Related]
28. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135 [TBL] [Abstract][Full Text] [Related]
29. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers. Sakakura C; Hagiwara A; Yamazaki J; Takagi T; Hosokawa K; Shimomura K; Kin S; Nakase Y; Fukuda K; Yamagishi H Hepatogastroenterology; 2004; 51(59):1350-3. PubMed ID: 15362750 [TBL] [Abstract][Full Text] [Related]
31. Relationship of preoperative serum CA-125 to survival in epithelial ovarian carcinoma. Geisler JP; Miller GA; Lee TH; Harwood RM; Wiemann MC; Geisler HE J Reprod Med; 1996 Mar; 41(3):140-2. PubMed ID: 8778409 [TBL] [Abstract][Full Text] [Related]
32. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Spirtos NM; Gross GM; Freddo JL; Ballon SC Gynecol Oncol; 1995 Mar; 56(3):345-52. PubMed ID: 7705667 [TBL] [Abstract][Full Text] [Related]
33. Clinical prognostic factors for ovarian metastasis in women with gastric cancer. Yook JH; Oh ST; Kim BS Hepatogastroenterology; 2007; 54(75):955-9. PubMed ID: 17591102 [TBL] [Abstract][Full Text] [Related]
34. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148 [TBL] [Abstract][Full Text] [Related]
35. [Laparoscopy in (apparently) benign ovarian tumors between benefit and catastrophy and the deceptive safety of laparoscopic lap sacs]. Wallwiener D; Diel IJ; Sohn C; Grischke EM; Brandsch R; Kurek R; Heberling D; Bastert G Zentralbl Gynakol; 1996; 118(2):53-61. PubMed ID: 8851090 [TBL] [Abstract][Full Text] [Related]
36. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277 [TBL] [Abstract][Full Text] [Related]
37. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors. Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718 [TBL] [Abstract][Full Text] [Related]
38. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373 [TBL] [Abstract][Full Text] [Related]
39. Colon cancer with metastasis to the ovary at time of initial diagnosis. Miller BE; Pittman B; Wan JY; Fleming M Gynecol Oncol; 1997 Sep; 66(3):368-71. PubMed ID: 9299247 [TBL] [Abstract][Full Text] [Related]
40. Incidence and location of para-aortic lymph node metastases in gynecologic malignancies. Flanagan CW; Mannel RS; Walker JL; Johnson GA J Am Coll Surg; 1995 Jul; 181(1):72-4. PubMed ID: 7599775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]